Antibiotic cement-coated plates for management of infected fractures.

Deep infection in the presence of an implant after open reduction and internal fixation is usually treated with removal of the implant, serial débridement procedures, lavage, intravenously administered antibiotics, and occasionally, placement of antibiotic-impregnated beads. If infection occurs during the early stages of bone healing, fracture stabilization might be compromised after implant removal. Osteomyelitis, unstable owing to a bone deficit or fracture, was treated with an antibiotic cement-coated (tobramycin and vancomycin) plate. The goal was successful eradication of infection with the patient remaining infection-free for 1 year. Four patients were treated with antibiotic-coated plates for osteomyelitis and all have achieved successful union, clinically free of signs of infection for more than 1 year. One patient experienced a prominent and painful plate, necessitating removal. Based on our experience, early aggressive débridement coupled with broad-spectrum antibiotic cement-coated plate insertion, provides fracture stability and helps eradicate the infection with 1 surgical procedure.

Practical aspects of foot and ankle arthroscopy.

Arthroscopy of the foot and ankle, although sometimes technically challenging, is a useful tool for the foot and ankle surgeon. Burman in 1931 was the first to attempt arthoscopy of the ankle joint and surmised that it was not a suitable joint for arthroscopy because of its narrow intra-articular space. With the development of smaller-diameter arthroscopes and improvements in joint distraction techniques, Watanabe was the first to present a series of 28 ankle arthroscopes in 1972. At present, arthroscopy is used not only to evaluate and treat intra-articular abnormalities but also for endoscopic and tendoscopic procedures.

Precise intraoperative 60 degrees Skin Z-plasty.

The primary objective of this tip is to assist foot and ankle surgeons in performing a precise 60 degrees lengthening Z-plasty in the operating room without the use of a template or protractor. A ruler and basic trigonometric principles are applied to the line of contracture to obtain consistent and reliable results.

Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway.

In order to examine the necessary structural features for a protein to promote lipid efflux by the ABCA1 transporter, synthetic peptides were tested on ABCA1-transfected cells (ABCA1 cells) and on control cells. L-37pA, an l amino acid peptide that contains two class-A amphipathic helices linked by proline, showed a 4-fold increase in cholesterol and phospholipid efflux from ABCA1 cells compared to control cells. The same peptide synthesized with a mixture of l and d amino acids was less effective than L-37pA in solubilizing dimyristoyl phosphatidyl choline vesicles and in effluxing lipids. In contrast, the 37pA peptide synthesized with all d amino acids (D-37pA) was as effective as L-37pA. Unlike apoA-I, L-37pA and D-37pA were also capable, although at a reduced rate, of causing lipid efflux independent of ABCA1 from control cells, Tangier disease cells, and paraformaldehyde fixed ABCA1 cells. The ability of peptides to bind to cells correlated with their lipid affinity. In summary, the amphipathic helix was found to be a key structural motif for peptide-mediated lipid efflux from ABCA1, but there was no stereoselective requirement. In addition, unlike apoA-I, synthetic peptides can also efflux lipid by a passive, energy-independent pathway that does not involve ABCA1 but does depend upon their lipid affinity.